Suchergebnisse - "Wong, Florence"

PubPharm (6)

1

Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2018

von Wong, F. | Jepsen, P. | Watson, H. | +1

2

Satavaptan treatment for ascites in patients with cirrhosis : a meta-analysis of effect on hepatic encephalopathy development

enthalten in: Metabolic brain disease | 2013

von Watson, H. | Jepsen, P. | Wong, F. | +3

3

Satavaptan for the management of ascites in cirrhosis : efficacy and safety across the spectrum of ascites severity

enthalten in: Gut | 2012

von Wong, F. | Watson, H. | Gerbes, A. | +5

4

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

enthalten in: Journal of hepatology | 2010

von Wong, F. | Gines, P. | Watson, H. | +5

CommentIn: J Hepatol. 2010 Aug;53(2):225-7. - PMID 20546963

5

Clinical trial : short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study

enthalten in: Alimentary pharmacology & therapeutics | 2010

von Ginès, P. | Wong, F. | Watson, H. | +42

6

Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia : a randomized trial

enthalten in: Hepatology (Baltimore, Md.) | 2008

von Ginès, P. | Wong, F. | Watson, H. | +34

1
[1]